Alkaline Phosphatase (ALP)

Blood

Comprehensive Metabolic Panel (CMP)

Alkaline phosphatase (ALP) is an enzyme released from the liver, bone, and intestine, and it serves as a marker of bile duct flow and bone turnover. A preventive practice tracks ALP to catch obstructions in the biliary system or shifts in bone metabolism that might otherwise go unnoticed.

What It Measures

Enzyme from liver, bone, and intestine; bile duct and bone health marker

Optimal vs. Lab Range

Longevity Optimal

50–100 U/L

Target range for optimal health and longevity based on research.

Standard Lab

44–147 U/L

Population-based reference range from standard labs.

Why It Matters

ALP is useful precisely because it draws from two very different sources, so the clinical story depends on which tissue is driving a change. Elevations can reflect bile duct obstruction, bone disease, Paget disease, hyperparathyroidism, or the normal rise seen in pregnancy, which is why the source is investigated rather than assumed. A low ALP is less common but can point to zinc or magnesium deficiency, malnutrition, hypothyroidism, or anemia, all of which matter for long-term vitality. Interpreting ALP alongside GGT and calcium helps separate a liver origin from a bone origin.

When Low

Zinc/magnesium deficiency, malnutrition, hypothyroidism, anemia

When High

Bile duct obstruction, bone disease, Paget disease, pregnancy, hyperparathyroidism

How to Optimize

Because ALP reflects distinct tissues, the first step is identifying whether an abnormal value comes from the liver, the bone, or elsewhere, which is a clinical assessment rather than a number to push in one direction. If the level is low and tied to nutritional gaps, repleting zinc or magnesium and correcting malnutrition can help. When the enzyme is elevated, the aim is diagnosing and addressing the biliary or bone process behind it. Companion markers such as GGT, bilirubin, and vitamin D guide that workup. Targets and treatment are individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Strong evidence

Key Interventions

Investigate liver vs. bone source

zinc/magnesium if low

Linked Compounds & Supplements

Zinc

Magnesium

Vitamin D

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum or plasma (venous draw)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Annual

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Alkaline Phosphatase (ALP).
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.